THE DYSFUNCTION OF COAGULATION-FACTOR VII PADUA RESULTS FROM SUBSTITUTION OF ARGININE-304 BY GLUTAMINE

被引:28
作者
JAMES, HL [1 ]
GIROLAMI, A [1 ]
HUBBARD, JG [1 ]
KUMAR, A [1 ]
FAIR, DS [1 ]
机构
[1] UNIV PADUA,SCH MED,INST SEMEIOT MED,I-35100 PADUA,ITALY
关键词
FACTOR-VII; VARIANT; MUTATION;
D O I
10.1016/0167-4781(93)90217-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study addresses whether a mutation in the factor VII(Padua) gene could explain the reduced activity of the inherited variant protein. All nine exons of the normal and Padua factor VII gene were amplified using the polymerase chain reaction, cloned into pUC19 and sequenced. A point mutation (G to A at nucleotide position 10 828) was found which results in the substitution of a glutamine (CAG) for arginine (CGG) at amino acid position 304. This substitution creates a PvuII restriction site useful in screening for the defect and in demonstrating homozygosity. This substitution involves an arginine residue in the catalytic domain within a Leu* * * * *Pro* * * * * *Cys motif which occurs in conserved region 5 in up to 16 coagulation and other serine proteinases. On the basis of conformational homology among serine proteinases, it is suggested that the observed amino acid substitution in factor VII(Padua) could cause structural changes affecting its activation and/or catalytic activity.
引用
收藏
页码:301 / 305
页数:5
相关论文
共 29 条
[1]  
ALEXANDER B, 1951, J CLIN INVEST, V30, P237
[2]  
BAJAJ SP, 1981, J BIOL CHEM, V256, P253
[3]   DEOXYNUCLEOSIDE PHOSPHORAMIDITES - A NEW CLASS OF KEY INTERMEDIATES FOR DEOXYPOLYNUCLEOTIDE SYNTHESIS [J].
BEAUCAGE, SL ;
CARUTHERS, MH .
TETRAHEDRON LETTERS, 1981, 22 (20) :1859-1862
[4]   POLYMORPHIC DNA REGION ADJACENT TO THE 5'-END OF THE HUMAN INSULIN GENE [J].
BELL, GI ;
KARAM, JH ;
RUTTER, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (09) :5759-5763
[5]  
BROZE GJ, 1980, J BIOL CHEM, V255, P1242
[6]  
DAVIS GL, 1986, BASIC METHODS MOL BI, P109
[7]  
DAVIS LG, 1986, BASIC METHODS MOL BI, P90
[8]  
FURIE B, 1982, J BIOL CHEM, V257, P3875
[9]  
GIROLAMI A, 1978, J LAB CLIN MED, V91, P387
[10]  
GIROLAMI A, 1982, ACTA HAEMATOL-BASEL, V68, P34, DOI 10.1159/000206945